ELV logo

Elevance Health (ELV) EBIT

annual EBIT:

$9.09B+$344.00M(+3.93%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ELV annual earnings before interest & taxes is $9.09 billion, with the most recent change of +$344.00 million (+3.93%) on December 31, 2024.
  • During the last 3 years, ELV annual EBIT has risen by +$296.00 million (+3.37%).
  • ELV annual EBIT is now at all-time high.

Performance

ELV EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVincome statement metrics

quarterly EBIT:

$3.14B+$2.19B(+232.03%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ELV quarterly earnings before interest & taxes is $3.14 billion, with the most recent change of +$2.19 billion (+232.03%) on March 31, 2025.
  • Over the past year, ELV quarterly EBIT has dropped by -$63.00 million (-1.97%).
  • ELV quarterly EBIT is now -29.31% below its all-time high of $4.44 billion, reached on December 31, 2009.

Performance

ELV quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVincome statement metrics

TTM EBIT:

$9.03B-$63.00M(-0.69%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ELV TTM earnings before interest & taxes is $9.03 billion, with the most recent change of -$63.00 million (-0.69%) on March 31, 2025.
  • Over the past year, ELV TTM EBIT has dropped by -$53.00 million (-0.58%).
  • ELV TTM EBIT is now -6.40% below its all-time high of $9.64 billion, reached on June 30, 2024.

Performance

ELV TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ELV EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.9%-2.0%-0.6%
3 y3 years+3.4%+25.3%+1.1%
5 y5 years+35.0%+37.6%+31.1%

ELV EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.5%-3.8%+232.0%-6.4%+6.8%
5 y5-yearat high+35.0%-6.2%+435.1%-6.4%+42.9%
alltimeall timeat high+9127.4%-29.3%+721.9%-6.4%>+9999.0%

ELV EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.14B(+232.0%)
$9.03B(-0.7%)
Dec 2024
$9.09B(+3.9%)
$946.00M(-43.5%)
$9.09B(-3.3%)
Sep 2024
-
$1.67B(-48.8%)
$9.40B(-2.5%)
Jun 2024
-
$3.27B(+1.9%)
$9.64B(+6.2%)
Mar 2024
-
$3.20B(+154.3%)
$9.08B(+3.8%)
Dec 2023
$8.74B(+3.5%)
$1.26B(-34.1%)
$8.74B(-0.2%)
Sep 2023
-
$1.91B(-29.2%)
$8.76B(-4.6%)
Jun 2023
-
$2.70B(-5.9%)
$9.19B(+4.2%)
Mar 2023
-
$2.87B(+125.3%)
$8.81B(+4.3%)
Dec 2022
$8.45B(-3.9%)
$1.27B(-45.6%)
$8.45B(-4.5%)
Sep 2022
-
$2.34B(+0.4%)
$8.85B(+1.6%)
Jun 2022
-
$2.33B(-7.1%)
$8.70B(-2.6%)
Mar 2022
-
$2.51B(+50.1%)
$8.93B(+1.6%)
Dec 2021
$8.79B(+25.2%)
$1.67B(-24.0%)
$8.79B(+11.0%)
Sep 2021
-
$2.20B(-14.1%)
$7.92B(+25.5%)
Jun 2021
-
$2.56B(+8.0%)
$6.32B(-11.1%)
Mar 2021
-
$2.37B(+195.3%)
$7.11B(+1.2%)
Dec 2020
$7.02B(+4.3%)
$802.00M(+36.6%)
$7.02B(-6.5%)
Sep 2020
-
$587.00M(-82.5%)
$7.51B(-12.6%)
Jun 2020
-
$3.35B(+46.7%)
$8.60B(+24.9%)
Mar 2020
-
$2.28B(+77.3%)
$6.88B(+2.2%)
Dec 2019
$6.73B(+15.6%)
$1.29B(-23.1%)
$6.73B(+9.0%)
Sep 2019
-
$1.67B(+2.3%)
$6.17B(+4.1%)
Jun 2019
-
$1.64B(-23.2%)
$5.93B(-1.0%)
Mar 2019
-
$2.13B(+191.3%)
$5.99B(+2.9%)
Dec 2018
$5.82B(+23.8%)
$732.00M(-48.8%)
$5.82B(+8.3%)
Sep 2018
-
$1.43B(-15.7%)
$5.38B(+3.1%)
Jun 2018
-
$1.70B(-13.6%)
$5.22B(+6.1%)
Mar 2018
-
$1.96B(+581.9%)
$4.92B(+4.6%)
Dec 2017
$4.70B(-10.9%)
$288.00M(-77.3%)
$4.70B(-10.4%)
Sep 2017
-
$1.27B(-9.1%)
$5.25B(-0.8%)
Jun 2017
-
$1.40B(-20.3%)
$5.29B(-4.3%)
Mar 2017
-
$1.75B(+109.5%)
$5.53B(+4.8%)
Dec 2016
$5.28B(-0.1%)
$835.50M(-36.2%)
$5.28B(+5.6%)
Sep 2016
-
$1.31B(-19.9%)
$5.00B(+0.3%)
Jun 2016
-
$1.63B(+9.0%)
$4.98B(-1.5%)
Mar 2016
-
$1.50B(+170.6%)
$5.06B(-4.2%)
Dec 2015
$5.28B(+6.3%)
$554.00M(-57.2%)
$5.28B(-8.4%)
Sep 2015
-
$1.29B(-24.4%)
$5.77B(+0.9%)
Jun 2015
-
$1.71B(-0.7%)
$5.72B(+5.6%)
Mar 2015
-
$1.72B(+65.6%)
$5.42B(+9.0%)
Dec 2014
$4.97B(+11.8%)
$1.04B(-16.2%)
$4.97B(+9.4%)
Sep 2014
-
$1.24B(-11.8%)
$4.54B(+4.9%)
Jun 2014
-
$1.41B(+10.4%)
$4.33B(+1.2%)
Mar 2014
-
$1.28B(+107.3%)
$4.28B(-3.6%)
Dec 2013
$4.44B
$615.70M(-40.3%)
$4.44B(-0.2%)
Sep 2013
-
$1.03B(-24.2%)
$4.45B(-2.8%)
DateAnnualQuarterlyTTM
Jun 2013
-
$1.36B(-5.3%)
$4.58B(+4.4%)
Mar 2013
-
$1.44B(+129.5%)
$4.39B(+0.4%)
Dec 2012
$4.37B(-0.4%)
$625.70M(-46.0%)
$4.37B(+0.8%)
Sep 2012
-
$1.16B(-0.6%)
$4.34B(+0.1%)
Jun 2012
-
$1.17B(-17.8%)
$4.33B(+1.3%)
Mar 2012
-
$1.42B(+140.2%)
$4.27B(-2.6%)
Dec 2011
$4.39B(-8.1%)
$590.80M(-48.8%)
$4.39B(-5.9%)
Sep 2011
-
$1.15B(+3.8%)
$4.66B(-1.9%)
Jun 2011
-
$1.11B(-27.5%)
$4.75B(-2.4%)
Mar 2011
-
$1.53B(+77.2%)
$4.87B(+2.1%)
Dec 2010
$4.77B(-39.2%)
$865.10M(-30.4%)
$4.77B(-42.8%)
Sep 2010
-
$1.24B(+1.1%)
$8.35B(+0.2%)
Jun 2010
-
$1.23B(-14.3%)
$8.34B(+0.7%)
Mar 2010
-
$1.43B(-67.7%)
$8.28B(+5.4%)
Dec 2009
$7.85B(+118.5%)
$4.44B(+261.9%)
$7.85B(+94.8%)
Sep 2009
-
$1.23B(+5.0%)
$4.03B(+16.1%)
Jun 2009
-
$1.17B(+15.8%)
$3.47B(-3.7%)
Mar 2009
-
$1.01B(+61.9%)
$3.60B(+0.3%)
Dec 2008
$3.59B(-37.0%)
$623.70M(-6.6%)
$3.59B(-18.7%)
Sep 2008
-
$667.80M(-48.7%)
$4.42B(-15.7%)
Jun 2008
-
$1.30B(+30.5%)
$5.24B(-2.1%)
Mar 2008
-
$998.20M(-31.1%)
$5.35B(-6.2%)
Dec 2007
$5.71B(+7.3%)
$1.45B(-2.9%)
$5.71B(+1.1%)
Sep 2007
-
$1.49B(+5.2%)
$5.64B(+2.4%)
Jun 2007
-
$1.42B(+5.0%)
$5.51B(+2.0%)
Mar 2007
-
$1.35B(-2.5%)
$5.40B(+1.6%)
Dec 2006
$5.32B(+29.2%)
$1.38B(+1.7%)
$5.32B(+5.7%)
Sep 2006
-
$1.36B(+4.1%)
$5.03B(+5.9%)
Jun 2006
-
$1.31B(+3.2%)
$4.75B(+8.0%)
Mar 2006
-
$1.27B(+15.2%)
$4.40B(+6.9%)
Dec 2005
$4.12B(+159.6%)
$1.10B(+1.8%)
$4.12B(+21.8%)
Sep 2005
-
$1.08B(+13.0%)
$3.38B(+24.9%)
Jun 2005
-
$955.50M(-2.7%)
$2.71B(+26.1%)
Mar 2005
-
$982.10M(+171.1%)
$2.14B(+35.2%)
Dec 2004
$1.59B(+1509.7%)
$362.30M(-10.6%)
$1.59B(+29.6%)
Sep 2004
-
$405.30M(+2.7%)
$1.22B(+5.4%)
Jun 2004
-
$394.80M(-6.7%)
$1.16B(+7.7%)
Mar 2004
-
$423.20M(+23.3%)
$1.08B(+122.3%)
Sep 2003
-
$343.10M(+10.2%)
$484.80M(+20.8%)
Jun 2003
-
$311.40M(-7.2%)
$401.40M(+50.4%)
Mar 2003
-
$335.40M(-166.4%)
$266.80M(-623.1%)
Dec 2002
$98.50M(-83.2%)
-$505.10M(-294.5%)
-$51.00M(-108.4%)
Sep 2002
-
$259.70M(+46.9%)
$610.30M(+12.7%)
Jun 2002
-
$176.80M(+904.5%)
$541.50M(+48.5%)
Mar 2002
-
$17.60M(-88.7%)
$364.70M(+5.1%)
Dec 2001
$584.80M
$156.20M(-18.2%)
$347.10M(+81.8%)
Sep 2001
-
$190.90M
$190.90M

FAQ

  • What is Elevance Health annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Elevance Health?
  • What is Elevance Health annual EBIT year-on-year change?
  • What is Elevance Health quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Elevance Health?
  • What is Elevance Health quarterly EBIT year-on-year change?
  • What is Elevance Health TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Elevance Health?
  • What is Elevance Health TTM EBIT year-on-year change?

What is Elevance Health annual earnings before interest & taxes?

The current annual EBIT of ELV is $9.09B

What is the all time high annual EBIT for Elevance Health?

Elevance Health all-time high annual earnings before interest & taxes is $9.09B

What is Elevance Health annual EBIT year-on-year change?

Over the past year, ELV annual earnings before interest & taxes has changed by +$344.00M (+3.93%)

What is Elevance Health quarterly earnings before interest & taxes?

The current quarterly EBIT of ELV is $3.14B

What is the all time high quarterly EBIT for Elevance Health?

Elevance Health all-time high quarterly earnings before interest & taxes is $4.44B

What is Elevance Health quarterly EBIT year-on-year change?

Over the past year, ELV quarterly earnings before interest & taxes has changed by -$63.00M (-1.97%)

What is Elevance Health TTM earnings before interest & taxes?

The current TTM EBIT of ELV is $9.03B

What is the all time high TTM EBIT for Elevance Health?

Elevance Health all-time high TTM earnings before interest & taxes is $9.64B

What is Elevance Health TTM EBIT year-on-year change?

Over the past year, ELV TTM earnings before interest & taxes has changed by -$53.00M (-0.58%)
On this page